Related Experiment Videos
Quo vadis cardiac positron emission tomography: qualitative or quantitative studies?
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Preferential radiosensitization of G1 checkpoint-deficient cells by methylxanthines.
International journal of radiation oncology, biology, physics·1996
2026 SNMMI Highlights Lecture: Cardiovascular Sciences.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Association of Early Same-Day Posttherapy Whole-Body SPECT/CT Using Visual RECIP 1.0 with Overall Survival During [177Lu]Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Normal-Organ Absorbed Dose and Response Assessment in α-Particle Radiopharmaceutical Therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
CXCR4-Targeted Molecular Imaging in Hematology and Oncology.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Targeted PET Imaging of Pseudomonas aeruginosa Using a [68Ga]Ga-Pyoverdines Cocktail.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Clinical and Biologic Characterization of a 3-Level Centiloid-Based Classification of Amyloid PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
National Economic Burden and Cost Drivers of Isolated Facial Fractures in the United States.
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons·2026
Disentangling History and Propagation Dependencies in Cross-Subject Knee Contact Stress Prediction Using a Shared MeshGraphNet Backbone.
Medical engineering & physics·2026
Low agreement among the equations in healthy children and young adults.
Journal of nephrology·2026
Association between psychological wellbeing and the COVID-19-related outcomes in Europeans aged ≥ 50 years old: The SHARE study.
Human vaccines & immunotherapeutics·2026